Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2022-10-25 Earnings Release
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
Q3/2022: Solid third quarter with slight sales growth in persistently volatile market environment; US business back on track with significant +45 % sales increase
Earnings Release Classification · 100% confidence The document is a news release dated October 25, 2022, titled "Q3/2022: Solid third quarter with slight sales growth..." and explicitly states it contains "Preliminary Results/Development of Sales". It provides key financial figures (sales, EBITDA expectations) for Q3 and the first nine months (9M/2022) compared to the prior year. It also mentions that the final results will be announced on November 14, 2022. This structure—a brief announcement of preliminary period results—fits the definition of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR), nor is it a transcript (CT) or a formal presentation (IP). Q3 2022
2022-10-25 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement dated October 21, 2022, titled 'Total Voting Rights Announcement' and references Article 41 of the WpHG (German Securities Trading Act). It explicitly states the 'New total number of voting rights' is 6,571,261 and details the 'Type of capital measure' as 'Other capital measure (Sec. 41 para. 1 WpHG)'. This content relates to changes in the total number of shares/voting rights, which falls under capital structure changes or regulatory notifications regarding share counts. Given the options, 'Share Issue/Capital Change' (SHA) is the most specific fit for announcing the total number of voting rights following a capital measure. It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It is a specific regulatory disclosure about the capital structure.
2022-10-21 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement (1674 characters) published via EQS, explicitly titled 'Total Voting Rights Announcement' and referencing Article 41 of the WpHG (German Securities Trading Act). It details a change related to the 'Total number of voting rights' due to a 'Conditional capital increase'. This type of regulatory disclosure regarding changes in voting rights or capital structure, especially when short and acting as a formal notification, fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS). Since it specifically details a capital measure ('Conditional capital increase') and the resulting total voting rights, 'CAP' (Capital/Financing Update) is the most precise fit among the specific categories, although it is a regulatory notification format. Given the focus on capital structure change (conditional capital increase) and voting rights count, CAP is selected over the general RNS.
2022-09-30 English
aap launches partnership with strategic investor from the Asian region and resolves on capital increase of around 10 %
Share Issue/Capital Change Classification · 99% confidence The document is an 'Ad-hoc' announcement dated September 5, 2022, disclosing an 'inside information acc. to Article 17 MAR'. The core content details a resolution by the Management Board to increase the company's share capital by issuing new shares via a private placement to a strategic investor. This action directly relates to fundraising, financing activities, and changes in the capital structure. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it involves shares, it is a resolution on a capital increase for financing, not a general share issue announcement (SHA) or a buyback (POS).
2022-09-05 English
Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR -0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022
Earnings Release Classification · 100% confidence The document is a press release dated August 12, 2022, detailing the financial results for Q2/2022 and H1/2022. It explicitly mentions 'Quarter Results' in the keywords and provides detailed figures for Sales and EBITDA for the specified periods, along with an outlook for the second half of 2022. This structure—a concise announcement of key financial figures for a recent period—aligns perfectly with the definition of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) or the detailed Interim Report (IR), but rather the initial public announcement of the results. H1 2022
2022-08-12 English
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.01.2022 bis zum 30.06.2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for the period 01.01.2022 to 30.06.2022 for aap Implantate AG. It contains detailed financial tables (Umsatz, EBITDA, Cash-Flow, Balance Sheet), a management report (Vorstandsvorwort), and a consolidated interim management report (Konzernzwischenlagebericht). Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2022
2022-08-12 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.